Yitzhack Asulin, MD
Obstetrics & Gynecology · Englewood, NJNPI 1073752556
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.4%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Asensus Surgical, Inc. at 29.8% of the total. Reporting peaked in 2022 at $4,316 and has fallen 93.2% since, to $293 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $44.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Asensus Surgical, Inc.$3K
- Medtronic$2K
- Axonics, Inc.$1K
- Intuitive Surgical$1K
- AbbVie$490
- Novo Nordisk$398
- plus $2K from 27 others
What the payments were for
- Travel & lodging$4,79145%
- Food & beverage$5,82954%
- Education$190%
- Gifts$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Asensus Surgical, Inc. | 10 | $3,196 |
| Medtronic(2 entities) | 31 | $1,860 |
| Axonics, Inc. | 13 | $1,378 |
| Intuitive Surgical | 12 | $1,245 |
| AbbVie(2 entities) | 40 | $490 |
| Novo Nordisk | 26 | $398 |
| Caldera Medical, Inc | 3 | $236 |
| Sumitomo Pharma America, Inc. | 13 | $214 |
| Pfizer | 9 | $181 |
| Myovant Sciences Inc. | 9 | $138 |
| Mayne Pharma Commercial LLC | 9 | $131 |
| Avion Pharmaceuticals | 10 | $127 |
| Aspira Women's Health Inc | 1 | $127 |
| Urovant Sciences Inc | 8 | $115 |
| Momentis Surgical Inc. | 1 | $95 |
| Lilly USA, LLC | 5 | $88 |
| Astellas Pharma US Inc | 6 | $82 |
| Johnson & Johnson | 4 | $69 |
| Davol Inc. | 2 | $65 |
| Exeltis, USA Inc. | 4 | $57 |
| Coloplast | 3 | $51 |
| Pacira Pharmaceuticals Incorporated | 3 | $48 |
| Dysis Medical, Inc. | 3 | $47 |
| Meditrina | 3 | $44 |
| Intra-sana Laboratories | 2 | $42 |
| Merz North America, Inc. | 1 | $41 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Vertex | 2 | $32 |
| Minerva Surgical, Inc | 2 | $24 |
| Conmed Corporation | 1 | $18 |
| LSI Solutions Inc | 1 | $15 |
| Baudax Bio Inc. | 1 | $14 |
| Coopersurgical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senhance$6,219
- INTERSTIM$1,349
- Axonics$1,134
- Senhance Surgical Robotics System$1,061
- Da Vinci Surgical System$1,037
- Bulkamid$1,028
- OVA1$127
- Desara$106
How this compares
$10,721 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 35 | $22,775 |
| MounjaroTirzepatide | 14 | $14,199 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $287 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $120 |
| Fluconazole | 12 | $65 |
| Triamcinolone Acetonide | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $82 | $22,77535 claims |
| Lilly USA, LLCMounjaro | $88 | $14,19914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Other obstetrics & gynecology in Englewood
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.